White Paper

“Spatial Phenotypic Signatures: A Novel Biomarker Class”

The spatial phenotypic signature, a new biomarker class, continues to demonstrate its predictive value for identifying patients who have a positive response to immunotherapy. Find out how this innovative biomarker testing approach is moving us closer to personalized medicine.

Complete this form to download the white paper.

Download the white paper to gain a better understanding of:

The predictive value of the tumor microenvironment

How multiplex immunofluorescence can improve the accuracy of PD-L1 testing

How an automated spatial biology workflow can support clinical trials and testing